With the help of a $2.4 million grant from the National Institutes of Health, a Virginia Tech professor is working on a vaccine that could help smokers conquer their nicotine addiction.
A new study found that Anoro Ellipta ((umeclidinium /vilanterol) showed a statistically significant improvement in lung function compared with tiotropium for COPD patients.
A study that compared the care delivered to patients in hospital emergency departments (EDs) for acute asthma attacks with data gathered more than 15 years earlier reveals inconsistencies in how well hospitals are meeting nationally established treatment guidelines.
IntelliQuit, the world’s first personal pocket size biosensor and ecosystem that biochemically measures tobacco consumption to help smokers quit, is now available on-line via Kickstarter.
Researchers have shown for the first time how bacteria can grow directly in the lungs of cystic fibrosis patients, which has provided tremendous insights into bacteria behavior and growth in chronic infections.
Cornell researchers have demonstrated how cigarette smoke results in cell death, a contributing factor in COPD development.
Patients using medication to treat asthma COPD and other diseases often purchased cigarettes while filling prescriptions at pharmacies.
The WHO Framework Convention on Tobacco Control (FCTC) recently concluded in Moscow and included the adoption of several landmark decisions.
Researchers have discovered an inhibitor for an enzyme called Sphingomyelin phosphodiesterase C (SMaseC) which is produced by the S. aureus bacterium and may harm the health of CF patients.
UCSF researchers have identified a novel factor that puts the brakes on airway smooth-muscle contraction relevant to asthma.